Page last updated: 2024-12-06

3-(3,4-dimethoxyphenyl)propanoic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

3-(3,4-dimethoxyphenyl)propanoic acid : A monocarboxylic acid that is propanoic acid substituted by a 3,4-dimethoxyphenyl group at position 3. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID75019
CHEMBL ID458049
CHEBI ID44235
SCHEMBL ID347209

Synonyms (64)

Synonym
AC-3251
BB 0256600
KUC108681N
ksc-11-266-2
6xo32zsp1d ,
unii-6xo32zsp1d
einecs 218-288-3
nsc 76043
3-(3,4-dimethoxyphenyl)-propionic acid
benzenepropanoic acid, 3,4-dimethoxy-
nsc-76043
2107-70-2
nsc76043
3-(3,4-dimethoxyphenyl)propionic acid
inchi=1/c11h14o4/c1-14-9-5-3-8(4-6-11(12)13)7-10(9)15-2/h3,5,7h,4,6h2,1-2h3,(h,12,13
2AY3
3-(3,4-dimethoxyphenyl)propanoic acid
3,4-dimethoxy-alpha-beta-dihydrocinnamic acid
DB04208
OPREA1_529953
3-(3,4-dimethoxyphenyl)propionic acid, 99%
MLS000779082
3-(3,4-dimethoxy-phenyl)-propionic acid
smr000415779
STK052389
3,4-dimethoxyhydrocinnamic acid
D1953
chebi:44235 ,
3,4-dimethoxy-hydrocinnamic acid
CHEMBL458049
AKOS000120617
A24438
NCGC00246520-01
BBL008121
HMS2761I14
FT-0613604
PS-4041
AM20060962
AB00263
3,4-dimethoxybenzenepropionic acid
.beta.-(3,4-dimethoxyphenyl)propionic acid
hydrocinnamic acid, 3,4-dimethoxy-
3,4-dimethoxybenzenepropanoic acid
SCHEMBL347209
3-(3,4-dimethoxyphenyl) propionic acid
SY004783
mfcd00002774
3-(3,4-dimethoxyphenyl)propanoic acid #
W-107576
STR05305
3-(3,4-dimethoxyphenyl)propanonic acid
HMS3604O10
DTXSID70175294
F3145-3172
J-510579
CS-W008790
(3,4-dimethoxyphenyl)propionic acid
Q27095035
3-(3',4'-dimethoxyphenyl)propanoic acid
HY-Y1620
PD006880
3-(3,4-dimethoxy-d6-phenyl)propanoic-d4acid
EN300-18221
Z57396496
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
monocarboxylic acidAn oxoacid containing a single carboxy group.
dimethoxybenzeneAny methoxybenzene that consists of a benzene skeleton substituted with two methoxy groups and its derivatives.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (23)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
chromobox protein homolog 1Homo sapiens (human)Potency100.00000.006026.168889.1251AID540317
importin subunit beta-1 isoform 1Homo sapiens (human)Potency6.51315.804836.130665.1308AID540253
snurportin-1Homo sapiens (human)Potency6.51315.804836.130665.1308AID540253
GTP-binding nuclear protein Ran isoform 1Homo sapiens (human)Potency6.51315.804816.996225.9290AID540253
DNA polymerase iota isoform a (long)Homo sapiens (human)Potency89.12510.050127.073689.1251AID588590
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, AROMATIC AMINO ACID AMINOTRANSFERASEParacoccus denitrificansKd280.0000280.00004,495.00006,900.0000AID977611
Chain B, AROMATIC AMINO ACID AMINOTRANSFERASEParacoccus denitrificansKd280.0000280.00004,495.00006,900.0000AID977611
Chain A, AROMATIC AMINO ACID AMINOTRANSFERASEParacoccus denitrificansKd280.0000280.00004,495.00006,900.0000AID977611
Chain B, AROMATIC AMINO ACID AMINOTRANSFERASEParacoccus denitrificansKd280.0000280.00004,495.00006,900.0000AID977611
Chain A, AROMATIC AMINO ACID AMINOTRANSFERASEParacoccus denitrificansKd280.0000280.00004,495.00006,900.0000AID977611
Chain B, AROMATIC AMINO ACID AMINOTRANSFERASEParacoccus denitrificansKd280.0000280.00004,495.00006,900.0000AID977611
Chain A, AROMATIC AMINO ACID AMINOTRANSFERASEParacoccus denitrificansKd280.0000280.00004,495.00006,900.0000AID977611
Chain B, AROMATIC AMINO ACID AMINOTRANSFERASEParacoccus denitrificansKd280.0000280.00004,495.00006,900.0000AID977611
Chain A, AROMATIC AMINO ACID AMINOTRANSFERASEParacoccus denitrificansKd280.0000280.00004,495.00006,900.0000AID977611
Chain B, AROMATIC AMINO ACID AMINOTRANSFERASEParacoccus denitrificansKd280.0000280.00004,495.00006,900.0000AID977611
Chain A, AROMATIC AMINO ACID AMINOTRANSFERASEParacoccus denitrificansKd280.0000280.00004,495.00006,900.0000AID977611
Chain B, AROMATIC AMINO ACID AMINOTRANSFERASEParacoccus denitrificansKd280.0000280.00004,495.00006,900.0000AID977611
Chain A, AROMATIC AMINO ACID AMINOTRANSFERASEParacoccus denitrificansKd280.0000280.00004,495.00006,900.0000AID977611
Chain B, AROMATIC AMINO ACID AMINOTRANSFERASEParacoccus denitrificansKd280.0000280.00004,495.00006,900.0000AID977611
Chain A, AROMATIC AMINO ACID AMINOTRANSFERASEParacoccus denitrificansKd280.0000280.00004,495.00006,900.0000AID977611
Chain B, AROMATIC AMINO ACID AMINOTRANSFERASEParacoccus denitrificansKd280.0000280.00004,495.00006,900.0000AID977611
Chain A, AROMATIC AMINO ACID AMINOTRANSFERASEParacoccus denitrificansKd280.0000280.00004,495.00006,900.0000AID977611
Chain B, AROMATIC AMINO ACID AMINOTRANSFERASEParacoccus denitrificansKd280.0000280.00004,495.00006,900.0000AID977611
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (27)

Assay IDTitleYearJournalArticle
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID1745845Primary qHTS for Inhibitors of ATXN expression
AID504810Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID504812Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID333180Inhibition of beta-hexosaminidase in anti-DNP IgE sensitized rat RBL2H3 cells at 100 uM after 10 mins2004Journal of natural products, Sep, Volume: 67, Issue:9
Structures of new beta-carboline-type alkaloids with antiallergic effects from Stellaria dichotoma(1,2).
AID715780Induction of cell differentiation in human U937 cells assessed as increase of CD88 expression at 500 uM after 72 hrs by FACS flow cytometer analysis2012Bioorganic & medicinal chemistry, Sep-15, Volume: 20, Issue:18
Structure-anti-leukemic activity relationship study of ortho-dihydroxycoumarins in U-937 cells: key role of the δ-lactone ring in determining differentiation-inducing potency and selective pro-apoptotic action.
AID715783Induction of cell differentiation in human U937 cells assessed as increase of CD11b and CD14 expression at 500 uM after 72 hrs by FACS flow cytometer analysis2012Bioorganic & medicinal chemistry, Sep-15, Volume: 20, Issue:18
Structure-anti-leukemic activity relationship study of ortho-dihydroxycoumarins in U-937 cells: key role of the δ-lactone ring in determining differentiation-inducing potency and selective pro-apoptotic action.
AID715802Cytotoxicity against human U937 cells after 48 hrs by trypan blue assay2012Bioorganic & medicinal chemistry, Sep-15, Volume: 20, Issue:18
Structure-anti-leukemic activity relationship study of ortho-dihydroxycoumarins in U-937 cells: key role of the δ-lactone ring in determining differentiation-inducing potency and selective pro-apoptotic action.
AID715803Antiproliferative activity against human U937 cells assessed as incorporation of [3H]-methyl-thymidine after 12 hrs by scintillation counting2012Bioorganic & medicinal chemistry, Sep-15, Volume: 20, Issue:18
Structure-anti-leukemic activity relationship study of ortho-dihydroxycoumarins in U-937 cells: key role of the δ-lactone ring in determining differentiation-inducing potency and selective pro-apoptotic action.
AID715795Induction of apoptosis in human U937 cells assessed as reduction of normal cells at 500 uM after 24 hrs by Annexin V-FITC double staining2012Bioorganic & medicinal chemistry, Sep-15, Volume: 20, Issue:18
Structure-anti-leukemic activity relationship study of ortho-dihydroxycoumarins in U-937 cells: key role of the δ-lactone ring in determining differentiation-inducing potency and selective pro-apoptotic action.
AID715771Pro-oxidant activity in human U937 cells assessed as DCF-DA oxidation at 10 to 250 uM after 48 hrs by fluorescence assay2012Bioorganic & medicinal chemistry, Sep-15, Volume: 20, Issue:18
Structure-anti-leukemic activity relationship study of ortho-dihydroxycoumarins in U-937 cells: key role of the δ-lactone ring in determining differentiation-inducing potency and selective pro-apoptotic action.
AID715777Induction of cell differentiation in human U937 cells assessed as increase of rhC5a-induced response at 500 uM after 72 hrs by FACS flow cytometer analysis2012Bioorganic & medicinal chemistry, Sep-15, Volume: 20, Issue:18
Structure-anti-leukemic activity relationship study of ortho-dihydroxycoumarins in U-937 cells: key role of the δ-lactone ring in determining differentiation-inducing potency and selective pro-apoptotic action.
AID715766Cytotoxicity against human PBMC at 500 uM after 48 hrs by trypan blue assay2012Bioorganic & medicinal chemistry, Sep-15, Volume: 20, Issue:18
Structure-anti-leukemic activity relationship study of ortho-dihydroxycoumarins in U-937 cells: key role of the δ-lactone ring in determining differentiation-inducing potency and selective pro-apoptotic action.
AID1248399Inhibition of alpha-amylase (unknown origin) relative to control2015Bioorganic & medicinal chemistry, Oct-15, Volume: 23, Issue:20
From carbohydrates to drug-like fragments: Rational development of novel α-amylase inhibitors.
AID715776Pro-oxidant activity in 0.1 M potassium phosphate buffer at pH 7.4 assessed as increase of oxidation potential by cyclic voltammetry analysis2012Bioorganic & medicinal chemistry, Sep-15, Volume: 20, Issue:18
Structure-anti-leukemic activity relationship study of ortho-dihydroxycoumarins in U-937 cells: key role of the δ-lactone ring in determining differentiation-inducing potency and selective pro-apoptotic action.
AID715770Induction of apoptosis in human Jurkat cells assessed as activation of caspase-3-mediated PARP cleavage at 500 uM after 24 hrs by colorimetric assay2012Bioorganic & medicinal chemistry, Sep-15, Volume: 20, Issue:18
Structure-anti-leukemic activity relationship study of ortho-dihydroxycoumarins in U-937 cells: key role of the δ-lactone ring in determining differentiation-inducing potency and selective pro-apoptotic action.
AID977611Experimentally measured binding affinity data (Kd) for protein-ligand complexes derived from PDB1999Biochemistry, Jan-26, Volume: 38, Issue:4
The active site of Paracoccus denitrificans aromatic amino acid aminotransferase has contrary properties: flexibility and rigidity.
AID1811Experimentally measured binding affinity data derived from PDB1999Biochemistry, Jan-26, Volume: 38, Issue:4
The active site of Paracoccus denitrificans aromatic amino acid aminotransferase has contrary properties: flexibility and rigidity.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (9)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (11.11)18.2507
2000's2 (22.22)29.6817
2010's5 (55.56)24.3611
2020's1 (11.11)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.63

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.63 (24.57)
Research Supply Index2.30 (2.92)
Research Growth Index4.93 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.63)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other9 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]